Report
of the Scientific Working Group for the Analysis Montreal, Canada; October 7 - 9, 2003 Joseph P. Bono The Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) is an International Working Group dedicated to the development and implementation of minimum standards for the identification of drug exhibits in forensic science laboratories. The primary objectives for the Group are:
The Eighth SWGDRUG Conference was held October 7-9, 2003 in Montreal, Canada. Core committee members in attendance included:
Two core committee members were unable to attend the Fall 2003 conference:
The 2003 SWDRUG conference included the addition of two new Core Committee members. Dr. Maria Eugenia Forero and Mr. Etienne van Zyl were welcomed as members of the Core Committee. Dr. Forero will represent South America, and Mr. van Zyl will represent Africa. This is another step in the process of increasing representation of the Core Committee to include a member from every continent. Accomplishments The accomplishments of the Montreal Conference included:
All recommendations described above are included in this report. Also included are the current SWGDRUG Glossary of Terms and contact information for all SWGDRUG Core Committee Members. SWGDRUG Publication (Part 2) The Core Committee agreed to publish a second edition of SWGDRUG recommendations which will include the following parts: Part I Code
of Professional Practice
Part II Education
and Training
Part III Methods of Analysis
Part IV Quality Assurance
Issues to Be Addressed at the Next SWGDRUG Conference:
PART I - A CODE OF PROFESSIONAL PRACTICE FOR DRUG ANALYSTS PREFACE - This Code of Professional Practice has been written specifically for analysts. However, it is important that their managers and the technicians and others who assist them in their work are equally aware of its provisions, and they support the analyst in adhering to these. Where appropriate, the provisions are also equally applicable to the technicians in the approach to their own work. SECTION 1: INTRODUCTION 1.1 A Code of Professional Practice is intended to provide the framework
of ethical values and scientific and legal obligations within which
the analyst should operate. Details are also usually provided on how
alleged breaches of the Code will be investigated, what sanctions are
available and how appeals should be pursued. 1.2 A Code of Professional Practice is essential to analysts and their
managers in helping them carry out their duties in a proper manner
and in making appropriate decisions when questions of ethics arise. 1.3 A Code of Professional Practice that is enforced and publicly
available is also a powerful means of demonstrating the professional
expectations of analysts and the reliability of their findings to others
in the criminal justice system and the public at large. 1.4 SWGDRUG recommends that all employers of analysts develop a Code
of Professional Practice and the means of dealing with breaches of
the Code. 1.5 SWGDRUG further recommends that all Codes of Professional Practice for analysts should include, as a minimum, provisions relating to their professional conduct, their casework and the reporting of their results, as provided in Section 2. SECTION 2: CODE OF PROFESSIONAL PRACTICE 2.1 Professional Conduct Analysts should:
2.2 Casework Analysts should:
2.3 Reporting Analysts should:
APPENDIX This appendix gives EXAMPLES to demonstrate the scope of the various provisions of the Code. Casework
Reporting
PART II - EDUCATION AND TRAINING SECTION 1: INTRODUCTION Part II recommends minimum education, training and experience for analysts practicing in laboratories that conduct seized drug analyses. It describes the types of activities necessary to continue professional development and reference literature required in laboratories where they practice. 1.1 Recommendations listed in Part II are intended to apply to any analyst who
SECTION 2: EDUCATION AND EXPERIENCE FOR ANALYSTS 2.1 The aim of this recommendation is that all analysts recruited in the future should have at least a bachelor’s degree, while allowing existing analysts without degrees to be retained as analysts. The minimum educational requirements for analysts are either:
SECTION 3: CONTINUING PROFESSIONAL DEVELOPMENT 3.1 All forensic scientists have an ongoing responsibility to remain current in their field. In addition, laboratories should provide support and opportunities for continuing professional development. Minimum continuing professional development requirements for a laboratory analyst are:
SECTION 4: INITIAL TRAINING REQUIREMENTS 4.1 These minimum requirements allow individual laboratories to structure their training program to meet their needs as it relates to type of casework encountered, analytical techniques, available instrumentation and level of preparedness of trainees. 4.2 There must be a documented training program, approved by laboratory management, that focuses on the development of theoretical and practical knowledge, skills and abilities necessary to examine seized drug samples and related materials. The training program must include the following:
4.3 Topic areas in the training program will include, as a minimum, the following:
4.4 An individual qualified to provide instruction must have demonstrated competence in the subject area and in the delivery of training. SECTION 5: REFERENCES AND DOCUMENTS 5.1 The following references and documents must be available and accessible to analysts:
PART III B - METHODS OF ANALYSIS/DRUG IDENTIFICATION SECTION 1: INTRODUCTION The purpose of PART III B is to recommend minimum standards for the forensic identification of commonly seized drugs. It is recognized that the correct identification of a drug or chemical depends on the use of an analytical scheme based on validated methods and the competence of the analyst. SWGDRUG requires the use of multiple uncorrelated techniques. It does not discourage the use of any particular method within an analytical scheme and it is accepted that unique requirements in different jurisdictions may dictate the actual practices followed by a particular laboratory. SECTION 2: CATEGORIZING ANALYTICAL TECHNIQUES 2.1 Techniques for the analysis of drug samples may be classified into three categories based on their discriminating power. Table 1 provides examples of these techniques listed in order of decreasing discriminating power from A to C. Table 1: Categories of Analytical Techniques
SECTION 3: IDENTIFICATION CRITERIA SWGDRUG recommends that laboratories adhere to the following minimum standards: 3.1 When a validated Category A technique is incorporated into an analytical scheme, then at least one other technique (from either Category A, B or C) must be used.
3.2 When a Category A technique is not used, then at least three different validated methods must be employed.
3.3 For the use of any method to be considered of value, test results must be considered “positive.” While “negative” test results provide useful information for ruling out the presence of a particular drug or drug class, these results have no value toward establishing the forensic identification of a drug. 3.4 In cases where hyphenated techniques are used (e.g., gas chromatography-mass spectrometry, liquid chromatography-diode array ultraviolet spectroscopy), they will be considered as separate techniques provided that the results from each are used. 3.5 Cannabis exhibits tend to have characteristics that are visually recognizable. Macroscopic and microscopic examinations of cannabis will be considered, exceptionally, as uncorrelated techniques from Category B when observations include documented details of botanical features. Additional testing must follow the scheme outlined in sections 3.1 or 3.2.
3.6 Examples of reviewable data are:
SECTION 4: COMMENT These recommendations are minimum standards for the forensic identification of commonly seized drugs. However, it should be recognized that they may not be sufficient for the identification of all drugs in all circumstances. Within these recommendations, it is up to the individual laboratory’s management to determine which combination of analytical techniques best satisfies the requirements of its jurisdiction. PART IV A - QUALITY ASSURANCE/GENERAL PRACTICES [Note: The Recommendations in this Part Are Currently Being Re-Evaluated and Updated] SECTION 1: INTRODUCTION Recommendations IN PART IV involving the analysis of seized drugs are limited to qualitative analysis only. Issues involving quantitative analysis will be taken up in a later version. It is the goal of a laboratory's drug analysis program to provide the customers of the laboratory's services access to quality drug analysis. It is the goal of these guidelines PART IV to provide a quality framework for managing the processing of drug casework, including handling of evidentiary material, management practices, analysis and reporting. These are minimum recommendations for practice. The term “evidence” has many meanings throughout the international community. In this document it is used to describe drug exhibits which enter a laboratory system. 1.1 QUALITY MANAGEMENT SYSTEM A documented quality management system must be established and maintained. Personnel responsible for this must be clearly designated and shall have direct access to the highest level of management concerning laboratory policy.
SECTION 2: PERSONNEL 2.1 JOB DESCRIPTION The job descriptions for all personnel should include responsibilities, duties and required skills. 2.2 DESIGNATED PERSONNEL AND RESPONSIBILITIES An individual (however titled) may be responsible for one or more of the following duties:
2.3 QUALIFICATIONS/EDUCATION
2.4 INITIAL TRAINING REQUIREMENTS
2.5 MAINTAINING COMPETENCE
SECTION 3: PHYSICAL PLANT 3.1 PHYSICAL PLANT REQUIREMENTS
SECTION 4: EVIDENCE CONTROL Laboratories shall have and follow a documented evidence control system to ensure the integrity of physical evidence. 4.1 RECEIVING AND IDENTIFYING EVIDENCE Laboratories must maintain records of requests for analysis and of the respective items of evidence. A unique identifier must be assigned to each case file or record. For chain-of-custody purposes, the evidence shall be compared to the submission documentation, any significant observations of irregularity should be documented in the case file or record, and the submitter informed promptly. This file or record must include, at least, the following:
4.2 INTEGRITY OF EVIDENCE Evidence must be properly secured. Appropriate storage conditions shall ensure that, insofar as possible, the composition of the seized material is not altered. All items must be safeguarded against loss or contamination. Any alteration of the evidence (e.g., repackaging) must be documented in writing. Procedures should be implemented to assure that samples are AND REMAIN properly labeled throughout the analytical process. 4.3 STORAGE OF EVIDENCE Access to the evidence storage area must be granted only to persons with authorization and access shall be controlled. A system shall be established to document the chain of custody FOR EVIDENCE IN LABORATORY CUSTODY. 4.4 DISPOSITION OF EVIDENCE Records must be kept regarding the disposition of all items of evidence. 4.5 DOCUMENTATION PROCEDURES All laboratory records such as results of analyses, measurements, notes, calibrations, chromatograms, spectra and reports shall be retained in a secure fashion. SECTION 5: ANALYTICAL PROCEDURES 5.1 ANALYTICAL PROCEDURES FOR DRUG ANALYSIS
5.2 MINIMUM REQUIREMENTS FOR THE VERIFICATION OF DRUG REFERENCE MATERIALS FOR FORENSIC DRUG ANALYSIS.
SECTION 6: INSTRUMENT/EQUIPMENT PERFORMANCE 6.1 INSTRUMENT PERFORMANCE Instruments must be routinely monitored to ensure that proper performance is maintained.
6.2 EQUIPMENT Only suitable and properly operating equipment shall be employed. Monitoring of equipment parameters shall be conducted and documented.
SECTION 7: CHEMICALS AND REAGENTS 7.1 CHEMICALS AND REAGENTS
SECTION 8: CASEWORK DOCUMENTATION, REPORT WRITING AND REVIEW 8.1 CASEWORK
8.2 REPORT WRITING
8.3 CASE REVIEW
SECTION 9: PROFICIENCY AND COMPETENCY TESTING Each laboratory should participate in at least an annual inter-laboratory proficiency testing program and should have written protocols for testing the competency of its laboratory analysts. 9.1 PROFICIENCY TESTING
9.2 COMPETENCY TESTING
SECTION 10: VALIDATION AND VERIFICATION 10.1 Method validation is required to demonstrate that the method is suitable for its intended purpose.
10.2 Laboratories adopting methods validated elsewhere should determine their own limit of detection and reproducibility. SECTION 11: LABORATORY AUDITS 11.1 Audits of laboratory operations should be conducted at least once a year. 11.2 Records of each audit must be maintained and should include the scope, date of the audit, name of the person conducting the audit, findings, and corrective actions taken, if necessary. SECTION 12: DEFICIENCY OF ANALYSIS In the course of examining seized drug samples and related materials, laboratories may expect to encounter some operations or results that are deficient in some manner. Each laboratory must have a written policy to deal with such deficiencies. 12.1 This policy must include the following:
Comment: It should be recognized that to be effective, the definition for "deficiency of analysis" must be relatively broad. As such, deficiencies may have markedly different degrees of seriousness. For example, a misidentification of a controlled substance would be very serious and perhaps require that either the methodology or the analyst be suspended pending appropriate remedial action, as determined by management. However, other deficiencies might be more clerical in nature, requiring a simple correction at the first line supervisory level, without any suspension of methodology or personnel. Thus, it may well be advantageous to identify the differing levels of seriousness for deficiencies and make the action required be commensurate with the seriousness. SECTION 13: HEALTH AND SAFETY The laboratory must have a documented health and safety program in place to meet the needs of the laboratory. 13.1 HEALTH AND SAFETY REQUIREMENTS
SECTION 14: DOCUMENTATION In addition to casework documentation, the forensic laboratory must maintain documentation on the following topics: 14.1 Test methods/procedures for drug analysis. 14.2 Reference standards (including source and verification). 14.3 Preparation and testing of reagents. 14.4 Evidence handling protocols. 14.5 Equipment calibration and maintenance. 14.6 Equipment inventory (e.g., manufacturer, model, serial number, acquisition date). 14.7 Proficiency testing. 14.8 Personnel training and qualification. 14.9 Quality assurance protocols and audits. 14.10 Health, safety and security protocols. 14.11 Validation data and results. * * * * * * * * * * * * * * * * * * * * * * * * * PART IV B - QUALITY ASSURANCE/VALIDATION OF ANALYTICAL METHODS SECTION 1. INTRODUCTION 1.1 Definition and purpose of Validation Validation is the confirmation by examination and the provision of objective evidence that the particular requirements for a specific intended use are fulfilled. There are numerous documents that address the topic of validation but there are few validation protocols for methods specific to seized drug analysis. 1.2 Analytical scheme An analytical scheme must be comprised of validated methods that are appropriate for the analyte.
1.3 Individual laboratory responsibility Each laboratory should determine whether their current standard operating procedures have been validated, verified or require further validation/verification. 1.4 Operational environment All methods must be validated or verified to demonstrate that they will perform in the normal operational environment when used by individuals expected to utilize the methods on casework. 1.5 Documentation The entire validation/verification process must be documented and the documentation must be retained. Documentation must include, but is not limited to the following: Personnel involved 1.6 Recommendation To meet the above requirements, SWGDRUG recommends that laboratories follow the applicable provisions of Section 2 [General Validation Plan] when validating seized drug analytical methods. SECTION 2. GENERAL VALIDATION PLAN 2.1 Purpose/Scope This is an introductory statement that will specify what is being tested, the purpose of the testing and the result(s) required for acceptance.
2.2 Analytical Method State exactly the method to be validated. It is essential that each step in the method is demonstrated to perform satisfactorily. Steps that constitute a method for the identification and/or quantification of seized drugs may include: Visual characterization (e.g., macroscopic examination)
Sampling
(representative or random, dry, homogenized, etc.)
Instrumental parameters and specifications
Software
applications
2.3 Reference materials in validation Appropriate reference material(s) must be used for qualitative and quantitative procedures. 2.4 Performance Characteristics
2.5 Uncertainty The contribution of random and systematic errors to method result uncertainty must be assessed and the expanded uncertainty derived for quantitative methods. 3. Quality Control Acceptance criteria for quality control parameters should be adopted prior to implementation of the method. 4. References A) The Fitness for Purpose of Analytical Methods, A Laboratory Guide to Method Validation and Related Topics, EURACHEM Guide, 1998. B) Federal Register, Part VIII, Department of Health and Human Services, March 1995, pp 11259-62. C) “Validating Analytical Chemistry Methods”, Enigma Analytical Training Course (Version 2000-1), Breckenridge, CO, 2000, pp 8-4, 8-5. * * * * * * * * * * * * * * * * * * * * * * * * * SWGDRUG GLOSSARY These definitions were developed and adopted by the SWGDRUG Core Committee from a variety of sources including The United Nations Glossary of Terms for Quality Assurance and Good Laboratory Practices. Accreditation Procedure by which an accreditation body formally recognizes that a laboratory or person is competent to carry out specific tasks. Accreditation Body Independent science-based organization that has the authority to grant accreditation. Accuracy Trueness and precision compose accuracy. Analysis Technical operation to determine one or more characteristics of, or to evaluate the performance of, a given product, material, equipment, physical phenomenon, process, or service according to a specified procedure. Analyst A designated person who:
Audit A review conducted to compare the various aspects of the laboratory’s performance with a standard for that performance. Blank Specimen or sample not containing the analyte. Calibration Set of operations that establishes, under specified conditions, the relationship between values indicated by a measuring instrument or measuring system, or values represented by a material measure, and the corresponding known values of a measurand. Certified Reference Material (CRM) A reference material, one or more of whose property values have been certified by a technical procedure, accompanied by or traceable to a certificate or other documentation that has been issued by a certifying body. Certifying Body Independent science-based organization that has the competence to grant certification. Chain of Custody Procedures and documents that account for the integrity of a sample by tracking its handling and storage from its point of collection to its final disposition. Controls Samples used to determine the validity of the calibration, that is, the linearity and stability of a quantitative test or determination over time. Controls are either prepared from the reference material (separately from the calibrators, that is, weighed or measured separately), purchased, or obtained from a pool of previously analyzed samples. Where possible, controls should be matrix-matched to samples and calibrators. Control Sample A standard of comparison for verifying or checking the finding of an experiment. Correlated Techniques Correlated techniques are those that have the same fundamental mechanism of characterization. For example, this would prevent the choice of two gas chromatographic tests both based on a partition mechanism (e.g., methylsiloxane and phenylmethylsiloxane) or two thin layer chromatographic systems both based on an adsorption mechanism. Deficiency of Analysis Any erroneous analytical result or interpretation, or any unapproved deviation from an established policy or procedure in an analysis. False Positive Test result that states that a drug is present when, in fact, such a drug is not present in an amount less than a threshold or designated cut-off concentration. Health & Safety Manager A designated person who is responsible for maintaining the laboratory health and safety program (including an annual review of the program) and who monitors compliance with the program. Independent Test Result Result obtained in a manner not influenced by any previous results on the same or similar material. Laboratory Facilities where analyses are performed by qualified personnel using adequate equipment. Limit of Detection: Limit of detection (LOD) is the smallest measured content from which it is possible to deduce the presence of the analyte with reasonable statistical certainty. Limit of Quantitation: The limit of quantitation (LoQ) is the lowest concentration of analyte that can be determined with an acceptable level of precision and trueness. Linearity: Defines the ability of the method to obtain test results proportional to the concentration of analyte. Method Detailed, defined procedure for performing an analysis. See Procedure. Procedure Specified, documented way to perform an activity. Proficiency Testing Ongoing process in which a series of proficiency samples, the characteristics of which are not known to the participants, are sent to laboratories on a regular basis. Each laboratory is tested for its accuracy in identifying the presence (or concentration) of the drug using its usual procedures. Qualitative Analysis Test that determines the presence or absence of specific drugs in the sample. Qualitative Test See Qualitative Analysis Quality Assurance (QA) System of activities whose purpose is to provide, to the producer or user of a product or a service, the assurance that it meets defined standards of quality with a stated level of confidence. Quality Assurance Manager A designated person who is responsible for maintaining the quality management system and who monitors compliance with the program. Quality Management That aspect of the overall management function that determines and implements the quality policy. Quality Manual Document stating the general quality policies, procedures and practices of an organization. Quantitative Analysis Procedure to determine the quantity of drug present in a sample. Quantitative Test See Quantitive Analysis Range Set of concentrations of analyte in which the error of a method is intended to lie within specified limits. Reference Material Material or substance one or more properties of which are sufficiently well established to be used for calibrating an apparatus, assessing a measurement method, or assigning values to materials. Repeatability Closeness of the agreement between the results of successive measurements of the same measurand carried out under the same conditions of measurement. Report Document containing a formal statement of results of tests carried out by a laboratory. Representative Sample Statistically, a sample that is similar to the population from which it was drawn. When a sample is representative, it can be used to make inferences about the population. The most effective way to get a representative sample is to use random methods to draw it. Analytically, it is a sample that is a portion of the original material selected in such a way that is possible to relate the analytical results obtained from it to the properties of the original material. Reproducibility Closeness of agreement between the results of successive measurements of the same analyte in identical material made by the same method under different conditions, e.g., different operators and different laboratories and considerably separated in time. Robustness The robustness of an analytical procedure is a measure of its capacity to remain unaffected by small, but deliberate variations in method parameters and provides an indication of its reliability during normal usage. Sample A portion of the whole material to be tested. Statistically, it is a set of data obtained from a population. Sampling Analytically, the whole set of operations needed to obtain a sample, including planning, collecting, recording, labeling, sealing, shipping, etc. Statistically, it is the process of determining properties of the whole population by collecting and analyzing data from a representative segment of it. Selectivity Extent to which a method can determine particular analyte(s) in a mixture without interference from the other components in the mixture. A method that is perfectly selective for an analyte or group of analytes is said to be specific. Specificity See Selectivity. Standard Operating Procedures (SOPs) A written document which details the method of an operation, analysis, or action whose techniques and procedures are thoroughly prescribed and which is accepted as the method for performing certain routine or repetitive tasks. Supervisory Chemist A designated person who has the overall responsibility and authority for the technical operations of the drug analysis section. Technical/Assistant Analyst A person who analyses evidence, but does not issue reports for court purposes. Technical Support Personnel A person who performs basic laboratory duties, but does not analyze evidence. Test See Analysis Traceable Ability to trace the history, application, or location of an entity by means of recorded identification. See also Chain of Custody. Traceability The property of a result of a measurement whereby it can be related to appropriate standards, generally international or national standards, through an unbroken chain of comparisons. Trueness: The closeness of agreement between the average value obtained from a large set of test results and an accepted reference value. Uncertainty: Parameter associated with the result of a measurement, that characterizes the dispersion of the values that could reasonably be attributed to the measurand. Validation Confirmation by examination and provision of objective evidence that the particular requirements for a specific intended use are fulfilled. Verification Confirmation by examination and provision of objective evidence that specified requirements have been fulfilled. (Method works in your lab as well as where it was validated.) * * * * * Back to Microgram Journal Index | Previous
|